Thyroid Eye Disease (TED) is a complex, autoimmune disease that can cause inflammation and remodeling of the tissues around the eyes when the immune system attacks tissues such as muscles and fat within the orbit (1,2). This autoimmune inflammation can cause symptoms such as eye bulging (proptosis), irritation, double vision (diplopia), and visual fatigue (3). Orbital decompression is one of the most effective surgical treatments for TED, particularly for reducing proptosis, relieving pressure, and protecting vision, and reducing exposure keratopathy (4). For many patients, a single orbital decompression procedure can achieve excellent results. However, a subset of patients may require additional interventions to fully address their symptoms or reach their desired outcome.
While this requirement for a second surgery can sound concerning, it is certainly not an uncommon occurrence, particularly when dealing with complex cases. It also reflects the individualized, staged nature of TED treatment rather than a failure of the first surgery.
Understanding why repeat decompression may be needed can help patients have realistic expectations and make informed decisions.
What Orbital Decompression Is Designed to Do
Orbital decompression works by creating more volume within the eye socket (orbit) (5). Surgeons remove portions of bone and/or orbital fat so that swollen tissues can expand into adjacent sinus spaces, allowing the eye to move posteriorly rather than pushing it forward.
This reduces eye bulging, relieves orbital pressure, allows full eyelid closure, and protects the optic nerve from compression. Because TED varies widely in severity and anatomy, decompression surgery is highly customized. Surgeons may remove one, two, or three orbital walls, or combine bone and fat removal, depending on the patient’s needs.
Why Some Patients Need More Than One Orbital Decompression
While most patients do achieve their primary goals with a single orbital decompression surgery, studies show that a small percentage of patients must undergo repeat decompression to achieve adequate results or address new issues. It is important to understand that rare cases of repeat decompression are not uncommon in TED management and as discussed above, TED treatment is often a personalized and protracted process. There are several reasons why a second decompression may be recommended.
Severity and Asymmetry of Disease
TED often manifests unevenly with one eye being more afflicted than the other. Patients may experience pronounced proptosis on one eye and asymmetric pressure or discomfort due to different degrees of muscle swelling or fat expansion. In such scenarios, one eye may require more decompression, while the other may be treated differently to restore or maintain symmetry. With this approach, the lingering subtle asymmetry that remains can be corrected with a second procedure.
Tissue Characteristics: “Stiff” vs. “Soft” Orbital Tissue
Another key factor influencing surgical outcome is the consistency of orbital tissue. Soft and fatty tissue tends to shift easily after decompression, whereas fibrotic or scar tissue (both of which are common in long-standing TED) may not move as well. In patients with an excess of fibrotic tissue, the eye may not settle back as much as expected or the decompression effect may be limited. In these cases, a second surgery may be needed to remove additional bone or fat and achieve better repositioning.
Progressive or Recurrent Disease
Although orbital decompression is typically undertaken during the inactive phase of TED, disease progression post-surgery is a documented event. Even after initial improvement, new swelling or fat expansion can occur with a return of proptosis and its associated symptoms. Because TED is an autoimmune condition, the underlying disease process can continue independently of surgery and when this happens, additional decompression may be necessary.
Functional vs. Cosmetic Goals
Orbital decompression is performed for both medical (functional) and cosmetic reasons. The functional goals are to relieve optic nerve compression, improve eyelid closure, and decrease orbital pressure. On the other hand, cosmetic goals include improving facial symmetry, reducing the “staring” phenotype and restoring the natural position of the eyes. Sometimes the first surgery may prioritize urgent functional needs, while the second procedure targets refining cosmetic results. This staged approach ensures that vision and eye health are addressed first, followed by aesthetic optimization.
Balancing Risks
Orbital decompression is a delicate procedure involving structures close to the brain, sinuses, and optic nerves. Extensive decompression increases the risk of complications such as double vision (diplopia), numbness in the cheek, upper lip, or temples, sinus complications, and, very rarely, serious vision loss. Following assessment of healing and calibration of results, a decision on additional intervention is made, thereby reducing risk while still achieving optimal outcomes.
Development or Worsening of Double Vision
Orbital decompression changes the alignment of the eye muscles and so, a very minor subset of patients may experience new or worsened double vision after surgery. This happens from the repositioning of the eye and changes in muscle balancing. In these cases, an additional surgery (either decompression or muscle surgery) may be needed to restore alignment.
Differences in Surgical Techniques
Orbital decompression is not a single uniform procedure and can involve medial wall decompression, lateral wall decompression, floor decompression, fat removal, and/or endoscopic (through the nose) approaches. Different techniques achieve different degrees and directions of decompression. For example, adding lateral wall decompression after a medial approach provides surgeons with the flexibility to fine-tune outcomes if necessary.
Undergoing a Second Surgery
A second orbital decompression is not a cause for concern. In fact, needing more than one orbital decompression often reflects the complexity of the disease, a careful, risk-minimizing surgical strategy and a personalized approach tailored to the patient. Almost all patients who undergo staged procedures ultimately achieve better symmetry, improved comfort and long-term stability.
A second decompression may be considered after the surgeon evaluates the degree of residual proptosis, symmetry between the eyes, presence of double vision, corneal health, eyelid function, and sometimes imaging (CT/MRI) to assess remaining orbital space. Additional surgery is usually delayed until healing from the first procedure is complete, as this allows tissues to stabilize and results to become clear.
You may be more likely to need repeat orbital decompression if you have severe proptosis, long-standing or fibrotic disease, significant asymmetry between eyes, persistent pressure or exposure symptoms, and/or incomplete response to initial surgery.
The Bottom Line
While orbital decompression is a powerful and often transformative treatment for thyroid eye disease, it is important to accept that sometimes additional procedures may be necessary. Due to the personalized and staged treatment approaches adopted in TED treatment, some patients may require more than one orbital decompression. This is usually because of residual bulging, asymmetry, tissue characteristics, disease progression and the need to balance safety and effectiveness. This customized treatment strategy is designed to achieve the best possible functional and aesthetic outcome.
If your surgeon recommends additional decompression, it is typically based on careful assessment and a goal of optimizing your long-term results and minimizing risks. If you are interested in learning more about a second intervention and have concerns, do not hesitate to schedule an appointment with Dr. Raymond Douglas.
References
- Wiersinga, W. M., Eckstein, A. K. & Zarkovic, M. Thyroid eye disease (Graves’ orbitopathy): clinical presentation, epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol 13, 600-614 (2025). https://doi.org/10.1016/S2213-8587(25)00066-X
- <autoimmune_diseases_and_your_environment_508.pdf>.
- Shah, S. S. & Patel, B. C. in StatPearls (2025).
- Rootman, D. B. Orbital decompression for thyroid eye disease. Surv Ophthalmol 63, 86-104 (2018). https://doi.org/10.1016/j.survophthal.2017.03.007
- Gupta, V. et al. Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease. Surv Ophthalmol 67, 858-874 (2022). https://doi.org/10.1016/j.survophthal.2021.08.010
English 
Spanish